Needham & Co.'s Mike Matson has updated his list of 25 most attractive public acquisition targets in medtech. Find out which two companies were added to the list!
Amanda Pedersen
July 6, 2018
28 Slides
Needham & Co.'s Mike Matson has updated his list of 25 most attractive public acquisition targets in medtech. Find out which two companies were added to the list!
About the Author(s)
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like